ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Key Financials
Operating Income
$98.3M
↑ 116.4%
Revenue
$829.4M
↑ 23258.2%
Net Income
$-1631000
↑ 99.7%
Shareholders' Equity
$466.1M
↑ 151.3%
EPS (Diluted)
$-0.01
↑ 99.8%
Cash & Equivalents
$184.4M
↑ 28.5%
Total Assets
$1.4B
↑ 21.5%
Operating Cash Flow
$179.6M
↑ 138.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ARWR |
| Company Name | ARROWHEAD PHARMACEUTICALS, INC. |
| CIK | 879407 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | DE |
| Phone | 626-696-4702 |